facebook twitter linkedin
investor relations

This material was prepared by a third party towards Selvita S.A. with its registered office in Kraków (hereunder: “Selvita”). Within the scope which was not authorized by Selvita’s management board, the description of factual circumstances regarding the activities of Selvita, embodied in this material presents merely opinion of the third party, in particular with respect to presented opinions, predictions, appraisals and forecasts of the financial data and future activity of Selvita and its results.

Therefore, Selvita does not warrant consistency of this material with the actual and legal situation. Neither Selvita, members of its corporate bodies, employees nor its consultants shall bear any liability for validity of opinions, predictions, appraisals, forecasts and any other date embodied in this material as well as for consequences of actions of any reader made on a basis of this material, in particular for the investment decisions or any losses resulting from use of this material.

Readers of this material shall make its own assessment, whether opinions or forecasts embodied therein are credible and adequate, in particular taking into account their investment strategy and actual and legal situation. In particular they should consult it with their independent financial and investment advisors. None of the information presented in this material shall constitute investment, legal, accounting or tax advice or a statement that any investment strategy is accurate or adequate, considering the circumstances of the reader.

Furthermore date presented in this material shall not constitute an offer to sell or purchase any financial instruments nor an invite the make such offer. It shall not be also not deemed as a recommendation for investment in any financial instrument nor an advertisement of such instruments.


Investor Relations

This Investor Relations site contains information about Selvita Group and its business relevant to the current and potential shareholders as well as customers. Chosen information about shareholders structure, Management and Supervisory Boards, corporate documents and presentations as well as current stock info can be found here.

Investor news

Consolidated Semmiannual Report of Selvita Group for H1 2016 (Summary)
Selvita Group Annual Report 2015 (Summary)
Summary of Consolidated Quarterly Report of Selvita Group for Q3 2015

Selvita shows dynamic revenue growth in H1 2015

Selvita shows strong revenue growth in the first quarter of 2015

Selvita doubled its revenues and achieved full-year profitability in 2014
Selvita has raised PLN 27.3 MM on its way to the main market of the Warsaw Stock Exchange
Selvita significantly improves financial results in Q3 2014
Selvita obtained PLN9.44 M financing for preclinical and clinical studies in SEL24 and SEL120 programs
H3 Biomedicine and Selvita Reach First Research Milestone in Precision Cancer Medicines Collaboration  
Selvita continues to improve financial results in Q1 2014

Selvita published a forecast of Q1 results and the backlog update for 2014